Ob/Gyn Medical News about postmenopausal hot flushes; acupuncture

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The acupuncture treatment for postmenopausal hot flushes (Acuflash) study: traditional Chinese medicine diagnoses and acupuncture points used, and their relation to the treatment response
Acupuncture in Medicine, 09/11/09

Borud EK et al. – The Acuflash study showed that traditional Chinese medicine (TCM) acupuncture as practised in Norway in addition to self–care can contribute to a clinically relevant reduction of hot flushes. The results did not differ between the TCM syndrome groups, and there were no major differences in point selection and frequency of use between responders and non–responders. Factors other than the TCM syndrome diagnoses and the point selection may be of importance regarding the outcome of the treatment.

<< Previous
Gene expression in chorionic villous samples at 11 weeks of...

Next >>
Prescription pattern of traditional Chinese medicine for...

Folic acid supplementation cures hot flushes in postmenopausal women
Medical Hypotheses, 10/08/09 Relevance Score: 80%

Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis
Therapeutics and Clinical Risk Management, 10/16/09 Relevance Score: 79%

Effects of arzoxifene on bone, lipid markers, and safety parameters in postmenopausal women with low bone mass
Osteoporosis International, 10/06/09 Relevance Score: 78%

Osteoporosis
OBG Management, 11/05/09 Relevance Score: 64%

Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes
Journal of Clinical Oncology, 11/12/09 Relevance Score: 46%